Cardiac Biomarker Diagnostic Test Kits Market

Cardiac Biomarker Diagnostic Test Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2026

  • Global Cardiac Biomarker Diagnostic Kits Market - Snbapshot

    The global cardiac biomarker diagnostic kits market was valued at US$ 2,100 Mn in 2017. It is anticipated to reach US$ 3,300 Bn by 2026, expanding at a CAGR of 5.4% from 2018 to 2026. Launch of high sensitivity cardiac biomarker kits, focus on research and development and new product launches by market players, strategic acquisitions and partnerships to enhance their geographic presence, rising prevalence of cardiac diseases, and shift in focus of the population toward treatment of chronic and lifestyle diseases are fuelling the market. 

    cardiac biomarker diagnostic kits market

    The global cardiac biomarker diagnostic kits market has been segmented based on product, disease indication, testing, end-user, and region. Based on product, the troponin test kits segment is projected to lead the market, in terms of revenue, and dominate the market during the forecast period, followed by the BNP test kit segment. It is anticipated to remain dominant during the forecast period. Expansion of the segment can be attributed to a rise in the demand for performing high sensitive troponin assay. Furthermore, increase in applications, owing to the growing focus on research in troponin to understand the interactions, and increasing number of studies on troponin interactions to streamline the cardiac biomarker development process are driving the segment. 

    In terms of end-user, the global cardiac biomarker diagnostic kits market has been categorized into hospitals, diagnostic centers, clinics, and others. Hospitals & diagnostic laboratories are an important channel for the usage of diagnostic products & offer a range of diagnosis solutions. They are an important channel for the usage of diagnostic products. 

    In terms of disease indication, the global cardiac biomarker diagnostic kits market has been classified into angina pectoris, myocardial infraction, cardiac heart failure, and others. The angina pectoris segment accounted for a major share of the global cardiac biomarker diagnostic kits market in 2017. The global market for cardiac biomarker diagnostic kits is driven primarily by the growing prevalence of cardiac disease that can lead to incidence of myocardial infraction, cardiac heart failure, and angina pectoris. Additionally, the concomitant rise in the associated mortality in worldwide population is fueling the demand for cardiac biomarker diagnostic kits. Rising demand for laboratory investigation for the diagnosis of cardiac diseases is propelling the market. 

    In terms of region, the global cardiac biomarker diagnostic kits market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cardiac biomarker diagnostic kits market, in terms of revenue, in 2017. It is projected to maintain its dominance during the forecast period. Presence of well-established players in the region and increasing research and development activities by these players are key attributable factors for North America’s dominance of the global cardiac biomarker diagnostic kits market. Asia Pacific is projected to be a highly attractive market for cardiac biomarker diagnostic kits, and the region is likely to exhibit a high attractiveness index. The market in Asia Pacific is projected to expand at a high CAGR during the forecast period, due to the rise of cardiac disease diagnosis which are expanding in countries in Asia Pacific. This, in turn, is attributable to well-developed health care infrastructure, increase in health care expenditure, and rise in the number of local manufacturers providing innovative products at lower cost. The market in Latin America is expected to expand at a moderate pace during the forecast period.

    Major players operating in the global cardiac biomarker diagnostic kits market are Abbott Laboratories, Hoffmann-La Roche AG, Bio-Rad Laboratories, Danaher Corporation, Siemens Healthineers, Thermo Fisher Scientific, bioMérieux, Randox Laboratories Ltd., and Ortho Clinical Diagnostics. They account for a significant share of the global market. The market is characterized by a large number of acquisitions, which has led to market consolidation and increasing dominance of the top players. In 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016. Companies operating in the cardiac biomarker diagnostic kits are focused on increasing their geographic presence by means of strategic collaborations with leading players in their respective domains and geographies.

The global cardiac biomarker diagnostic kits market has been segmented as follows:

Disease Indication

  • Angina pectoris
  • Myocardial Infraction (MI)
  • Cardiac Heart Failure
  • Others

Product

  • Troponin Test Kits
  • CK-MB Test Kits
  • Myoglobin Test Kits
  • BNP Test Kit
  • C-reactive Protein (hsCRP)
  • Other Biomarkers (galectin-3, H-FABP, myeloperoxidase, ischemia-modified albumin, and homocysteine)

Testing

  • Laboratory Testing
  • Pont-of-care Testing

End-user

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Australia & New Zealand
    • ASEAN
    • Japan
    • Rest of APAC
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • North Africa
    • South Africa
    • Rest of MEA

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market

    4. Market Overview
         4.1. Introduction
               4.1.1. Products Definition
               4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Market Dynamics
               4.3.1. Drivers
               4.3.2. Restraints
               4.3.3. Opportunities
         4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2016–2026
               4.4.1. Market Revenue Projections (US$ Mn)
         4.5. Porter’s Five Force Analysis

    5. Key Insights
         5.1. Regulatory Scenario by Region/Globally
         5.2. Key Mergers & Acquisitions
         5.3. Reimbursement Scenario 
         5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries
         5.5. Top 3 players operating in the market space

    6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Product 
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
               6.3.1. Troponin Test Kits 
               6.3.2. CK-MB Test Kits
               6.3.3. Myoglobin Test Kits
               6.3.4. BNP Test Kit
               6.3.5. C-reactive Protein (hsCRP)
               6.3.6. Others
         6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product 

    7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing 
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
               7.3.1. Laboratory Testing
               7.3.2. Pont-of-care Testing
         7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing 

    8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Disease Indication 
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
               8.3.1. AngiStent Type Pectoris
               8.3.2. Myocardial Infraction
               8.3.3. Cardiac Heart Failure
               8.3.4. Other
         8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication 

    9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user 
         9.1. Introduction & Definition
         9.2. Key Findings / Developments
         9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
               9.3.1. Hospitals
               9.3.2. Clinics
               9.3.3. Diagnostic Laboratory
               9.3.4. Others
         9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user 

    10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region
         10.1. Key Findings
         10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region
               10.2.1. North America 
               10.2.2. Europe 
               10.2.3. Asia Pacific 
               10.2.4. Latin America 
               10.2.5. Middle East & Africa 
         10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region

    11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
         11.1. Introduction
               11.1.1. Key Findings
         11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
               11.2.1. Troponin Test Kits 
               11.2.2. CK-MB Test Kits
               11.2.3. Myoglobin Test Kits
               11.2.4. BNP Test Kit
               11.2.5. C-reactive Protein (hsCRP)
               11.2.6. Others
         11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
               11.3.1. Laboratory Testing
               11.3.2. Pont-of-care Testing
         11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
               11.4.1. AngiStent Type Pectoris
               11.4.2. Myocardial Infraction
               11.4.3. Cardiac Heart Failure
               11.4.4. Other
         11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
               11.5.1. Hospitals
               11.5.2. Clinics
               11.5.3. Diagnostic Laboratory
               11.5.4. Others
         11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2016–2026
               11.6.1. U.S.
               11.6.2. Canada
         11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
               11.7.1. By Product 
               11.7.2. By Testing 
               11.7.3. By Disease Indication 
               11.7.4. By End-user 
               11.7.5. By Country

    12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
         12.1. Introduction
               12.1.1. Key Findings
         12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
               12.2.1. Troponin Test Kits 
               12.2.2. CK-MB Test Kits
               12.2.3. Myoglobin Test Kits
               12.2.4. BNP Test Kit
               12.2.5. C-reactive Protein (hsCRP)
               12.2.6. Others
         12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
               12.3.1. Laboratory Testing
               12.3.2. Pont-of-care Testing
         12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
               12.4.1. AngiStent Type Pectoris
               12.4.2. Myocardial Infraction
               12.4.3. Cardiac Heart Failure
               12.4.4. Other
         12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
               12.5.1. Hospitals
               12.5.2. Clinics
               12.5.3. Diagnostic Laboratory
               12.5.4. Others
         12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
               12.6.1. Germany
               12.6.2. U.K.
               12.6.3. France
               12.6.4. Spain
               12.6.5. Italy
               12.6.6. Rest of Europe
         12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
               12.7.1. By Product 
               12.7.2. By Testing 
               12.7.3. by Disease Indication 
               12.7.4. by End-user 
               12.7.5. by Country/Sub-region

    13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
         13.1. Introduction
               13.1.1. Key Findings
         13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
               13.2.1. Troponin Test Kits 
               13.2.2. CK-MB Test Kits
               13.2.3. Myoglobin Test Kits
               13.2.4. BNP Test Kit
               13.2.5. C-reactive Protein (hsCRP)
               13.2.6. Others
         13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
               13.3.1. Laboratory Testing
               13.3.2. Pont-of-care Testing
         13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
               13.4.1. AngiStent Type Pectoris
               13.4.2. Myocardial Infraction
               13.4.3. Cardiac Heart Failure
               13.4.4. Other
         13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
               13.5.1. Hospitals
               13.5.2. Clinics
               13.5.3. Diagnostic Laboratory
               13.5.4. Others
         13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
               13.6.1. China
               13.6.2. Japan
               13.6.3. India
               13.6.4. Australia & New Zealand
               13.6.5. Rest of Asia Pacific
         13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
               13.7.1. By Product 
               13.7.2. By Testing 
               13.7.3. By Disease Indication 
               13.7.4. By End-user 
               13.7.5. By Country/Sub-region

    14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
         14.1. Introduction
               14.1.1. Key Findings
         14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
               14.2.1. Troponin Test Kits 
               14.2.2. CK-MB Test Kits
               14.2.3. Myoglobin Test Kits
               14.2.4. BNP Test Kit
               14.2.5. C-reactive Protein (hsCRP)
               14.2.6. Others
         14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
               14.3.1. Laboratory Testing
               14.3.2. Pont-of-care Testing
         14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
               14.4.1. AngiStent Type Pectoris
               14.4.2. Myocardial Infraction
               14.4.3. Cardiac Heart Failure
               14.4.4. Other
         14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
               14.5.1. Hospitals
               14.5.2. Clinics
               14.5.3. Diagnostic Laboratory
               14.5.4. Others
         14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
               14.6.1. Brazil
               14.6.2. Mexico
               14.6.3. Rest of Latin America
         14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
               14.7.1. By Product 
               14.7.2. By Testing 
               14.7.3. By Disease Indication 
               14.7.4. By End-user 
               14.7.5. By Country/Sub-region

    15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
         15.1. Introduction
               15.1.1. Key Findings
         15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
               15.2.1. Troponin Test Kits 
               15.2.2. CK-MB Test Kits
               15.2.3. Myoglobin Test Kits
               15.2.4. BNP Test Kit
               15.2.5. C-reactive Protein (hsCRP)
               15.2.6. Others
         15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
               15.3.1. Laboratory Testing
               15.3.2. Pont-of-care Testing
         15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
               15.4.1. AngiStent Type Pectoris
               15.4.2. Myocardial Infraction
               15.4.3. Cardiac Heart Failure
               15.4.4. Other
         15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
               15.5.1. Hospitals
               15.5.2. Clinics
               15.5.3. Diagnostic Laboratory
               15.5.4. Others
         15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
               15.6.1. GCC Countries
               15.6.2. South Africa
               15.6.3. Rest of Middle East & Africa
         15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis 
               15.7.1. By Product 
               15.7.2. By Testing 
               15.7.3. By Disease Indication 
               15.7.4. By End-user 
               15.7.5. By Country/Sub-region

    16. Competition Landscape
         16.1. Market Player – Competition Matrix (by Tier and Size of companies)
         16.2. Market Share Analysis by Company (2017)
         16.3. Competitive Business Strategies
         16.4. Company Profiles
               16.4.1. Abbott Laboratories Ltd.
                         16.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.1.2. Business Overview
                         16.4.1.3. Product Portfolio 
                         16.4.1.4. Financial Overview 
                         16.4.1.5. SWOT Analysis 
               16.4.2. Hoffmann-La Roche AG
                         16.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.2.2. Business Overview
                         16.4.2.3. Product Portfolio 
                         16.4.2.4. Financial Overview 
                         16.4.2.5. SWOT Analysis 
               16.4.3. Bio-Rad Laboratories
                         16.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.3.2. Business Overview
                         16.4.3.3. Product Portfolio 
                         16.4.3.4. Financial Overview 
                         16.4.3.5. SWOT Analysis 
               16.4.4. Danaher Corporation
                         16.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.4.2. Business Overview
                         16.4.4.3. Product Portfolio 
                         16.4.4.4. Financial Overview 
                         16.4.4.5. SWOT Analysis 
               16.4.5. Seimens Healthineers
                         16.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.5.2. Business Overview
                         16.4.5.3. Product Portfolio 
                         16.4.5.4. Financial Overview 
                         16.4.5.5. SWOT Analysis 
               16.4.6. Thermofisher Scientific
                         16.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.6.2. Business Overview
                         16.4.6.3. Product Portfolio 
                         16.4.6.4. Financial Overview 
                         16.4.6.5. SWOT Analysis 
               16.4.7. bioMérieux
                         16.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.7.2. Business Overview
                         16.4.7.3. Product Portfolio 
                         16.4.7.4. Financial Overview 
                         16.4.7.5. SWOT Analysis 
               16.4.8. Ortho Clinical Diagnostics 
                         16.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
                         16.4.8.2. Business Overview
                         16.4.8.3. Product Portfolio 
                         16.4.8.4. Financial Overview 
                         16.4.8.5. SWOT Analysis 

    List of Tables

    Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
    Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2016–2026
    Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
    Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
    Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
    Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
    Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
    Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
    Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
    Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

    List of Figures

    Figure 01: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
    Figure 02: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
    Figure 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Troponin Test Kits, 2016–2026
    Figure 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by CK-MB Test Kits, 2016–2026
    Figure 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myoglobin Test Kits, 2016–2026
    Figure 06: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by BNP Test Kit, 2016–2026
    Figure 07: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by C-reactive Protein (hsCRP), 2016–2026
    Figure 08: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Other Biomarkers, 2016–2026
    Figure 09: Global Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
    Figure 10: Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
    Figure 11: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Angina Pectoris, 2016–2026
    Figure 12: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Myocardial Infraction (MI), 2016–2026
    Figure 13: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Cardiac Heart Failure, 2016–2026
    Figure 14: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
    Figure 15: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
    Figure 16: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Laboratory Testing, 2016–2026
    Figure 17: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Pont-of-care testing, 2016–2026
    Figure 18: Global Cardiac Biomarker Diagnostic Kits  Market Attractiveness Analysis, by Testing, 2018–2026
    Figure 19: Global Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 20: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Hospitals, 2016–2026
    Figure 21: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Clinics, 2016–2026
    Figure 22: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) and Y-o-Y Growth, by Diagnostic Laboratory, 2016–2026
    Figure 23: Global Cardiac Biomarker Diagnostic Kits  Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 24: Cardiac Biomarker Diagnostic Kits  Market Value Share Analysis, by Region, 2017 and 2026
    Figure 25: Global Cardiac Biomarker Diagnostic Kits  Market Attractiveness Analysis by Region, 2018–2026
    Figure 26: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 27: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
    Figure 28: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
    Figure 29: North America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
    Figure 30: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
    Figure 31: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
    Figure 32: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
    Figure 33: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 34: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 35: North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018–2026
    Figure 36: North America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026
    Figure 37: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 38: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
    Figure 39: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
    Figure 40: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
    Figure 41: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
    Figure 42: Europe Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
    Figure 43: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
    Figure 44: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 45: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 46: Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 47: Europe Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 48: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 49: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
    Figure 50: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
    Figure 51: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
    Figure 52: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
    Figure 53: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
    Figure 54: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
    Figure 55: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 56: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 57: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 58: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 59: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 60: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
    Figure 61: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
    Figure 62: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
    Figure 63: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
    Figure 64: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
    Figure 65: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
    Figure 66: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 67: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 68: Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 69: Latin America Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 70: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 71: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Product, 2017 and 2026
    Figure 72: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product, 2018–2026
    Figure 73: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share, by Disease Indication, 2017 and 2026
    Figure 74: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication, 2018–2026
    Figure 75: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Testing, 2017 and 2026
    Figure 76: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Testing, 2018–2026
    Figure 77: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 78: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 79: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis, by Country, 2018–2026
    Figure 80: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Share Analysis, by Country, 2017 and 2026

Copyright © Transparency Market Research, Inc. All Rights reserved